109 related articles for article (PubMed ID: 7691368)
21. Increased serum interleukin-32 levels in patients with Behçet's disease.
Ha YJ; Park JS; Kang MI; Lee SK; Park YB; Lee SW
Int J Rheum Dis; 2018 Dec; 21(12):2167-2174. PubMed ID: 28378461
[TBL] [Abstract][Full Text] [Related]
22. Increased Serum Antibody Titer against HPV-16 Antigen in Patients with Behçet's Disease.
Kim KY; Kim DY; Seo J; Ahn Y; Kim DS
J Korean Med Sci; 2017 Apr; 32(4):599-604. PubMed ID: 28244285
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of the RheumaStrip ANA profile test: a rapid test strip procedure for simultaneously determining antibodies to autoantigens U1-ribonucleoprotein (U1-RNP), Sm, SS-A/Ro, SS-B/La, and to native DNA.
Paxton H; Bendele T; O'Connor L; Haynes DC
Clin Chem; 1990 May; 36(5):792-7. PubMed ID: 2140076
[TBL] [Abstract][Full Text] [Related]
24. Anticardiolipin antibodies in Behçet's disease: a reassessment.
Tokay S; Direskeneli H; Yurdakul S; Akoglu T
Rheumatology (Oxford); 2001 Feb; 40(2):192-5. PubMed ID: 11257156
[TBL] [Abstract][Full Text] [Related]
25. Anticardiolipin antibodies in Behçet's disease.
Bergman R; Lorber M; Lerner M; Brik R; Friedman-Birnbaum R
J Dermatol; 1990 Mar; 17(3):164-7. PubMed ID: 2355142
[TBL] [Abstract][Full Text] [Related]
26. Anticardiolipin antibodies and retinal vascular complications in Behçet's disease.
Ozdemir Y; Onder F; Yarangümeli A; Küçükkuyumcu C; Kural G
Ophthalmic Surg Lasers; 1997 Aug; 28(8):653-6. PubMed ID: 9268996
[TBL] [Abstract][Full Text] [Related]
27. Decreased serum level of antibody against human cytomegalovirus in patients with Behçet's disease.
Lee EB; Kwon YJ; Shin KC; Song YW; Park CG; Hwang ES; Cha CY
Rheumatol Int; 2005 Jan; 25(1):33-6. PubMed ID: 14600786
[TBL] [Abstract][Full Text] [Related]
28. Presence of autoantibodies in women with unexplained infertility.
Taylor PV; Campbell JM; Scott JS
Am J Obstet Gynecol; 1989 Aug; 161(2):377-9. PubMed ID: 2669491
[TBL] [Abstract][Full Text] [Related]
29. Cardiac involvement in Behçet's disease.
Morelli S; Perrone C; Ferrante L; Sgreccia A; Priori R; Voci P; Accorinti M; Pivetti-Pezzi P; Valesini G
Cardiology; 1997; 88(6):513-7. PubMed ID: 9397304
[TBL] [Abstract][Full Text] [Related]
30. Chronic signs of memory B cell activation in patients with Behçet's disease are partially restored by anti-tumour necrosis factor treatment.
van der Houwen TB; van Hagen PM; Timmermans WM; Bartol SJ; Lam KH; Kappen JH; van Zelm MC; van Laar JA
Rheumatology (Oxford); 2017 Jan; 56(1):134-144. PubMed ID: 27744360
[TBL] [Abstract][Full Text] [Related]
31. Alpha tropomyosin as a self-antigen in patients with Behçet's disease.
Mahesh SP; Li Z; Buggage R; Mor F; Cohen IR; Chew EY; Nussenblatt RB
Clin Exp Immunol; 2005 May; 140(2):368-75. PubMed ID: 15807864
[TBL] [Abstract][Full Text] [Related]
32. Gastric parietal cell and thyroid autoantibodies in patients with Behcet's disease.
Lin HP; Wu YH; Yu-Fong Chang J; Wang YP; Chen HM; Sun A
J Formos Med Assoc; 2018 Jun; 117(6):505-511. PubMed ID: 29549982
[TBL] [Abstract][Full Text] [Related]
33. Serum anti-lysozyme is associated with disease activity of Behçet's disease.
Park JS; Kang MI; Ha YJ; Song JJ; Park YB; Lee SK; Lee SW
Int J Rheum Dis; 2017 Feb; 20(2):261-268. PubMed ID: 26890818
[TBL] [Abstract][Full Text] [Related]
34. Antibodies to endothelial cells in Behçet's disease: cell-binding heterogeneity and association with clinical activity.
Cervera R; Navarro M; López-Soto A; Cid MC; Font J; Esparza J; Reverter JC; Monteagudo J; Ingelmo M; Urbano-Márquez A
Ann Rheum Dis; 1994 Apr; 53(4):265-7. PubMed ID: 8203957
[TBL] [Abstract][Full Text] [Related]
35. Up-regulation of Th17 and related cytokines in Behçet's disease corresponding to disease activity.
Na SY; Park MJ; Park S; Lee ES
Clin Exp Rheumatol; 2013; 31(3 Suppl 77):32-40. PubMed ID: 24064012
[TBL] [Abstract][Full Text] [Related]
36. Gastric parietal cell and thyroid autoantibodies in Behcet's disease patients with or without atrophic glossitis.
Wu YH; Chang JY; Wang YP; Wu YC; Chen HM; Sun A
J Formos Med Assoc; 2018 Aug; 117(8):691-696. PubMed ID: 29653880
[TBL] [Abstract][Full Text] [Related]
37. Serum IL-33 levels and skin mRNA expression in Behçet's disease.
Hamzaoui K; Kaabachi W; Fazaa B; Zakraoui L; Mili-Boussen I; Haj-Sassi F
Clin Exp Rheumatol; 2013; 31(3 Suppl 77):6-14. PubMed ID: 23464866
[TBL] [Abstract][Full Text] [Related]
38. [Serum immunoglobulins in Behçet's disease].
Kogure M; Motoji K; Kawano F; Hara H
Nippon Ganka Gakkai Zasshi; 1971 Jun; 75(6):1359-62. PubMed ID: 5001130
[No Abstract] [Full Text] [Related]
39. The relationship between plasma homocysteine level and HLA-B51 in patients with Behcet's disease: a case-control study.
Shadmanfar S; Shahram F; Nadji A; Akhlaghi M; Faezi ST; Sadeghi-Abdollahi B; Faridar A; Madanchi N; Davatchi F
Int J Rheum Dis; 2014 May; 17(4):466-70. PubMed ID: 24428874
[TBL] [Abstract][Full Text] [Related]
40. HnRNP A1 is Involved in Deep Vein Thrombosis Patients with Behçet's Disease.
Chen P; Zhang C; Liu C; Zhang L; Yang C; Chen G; Ma D; Tian Y; Du H
EBioMedicine; 2016 Apr; 6():215-221. PubMed ID: 27211563
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
